KPMG, Others Expect India State Of Gujarat To Be Global Center Of Generics, R&D (India)
This article was originally published in PharmAsia News
Executive Summary
The financial advisory company KPMG said in a report the Indian state of Gujarat stands to become the global center for generic drugs, research and development and manufacturing services. The state already has attracted several pharmaceutical companies expected to be leaders in generics, according to one health care CEO, becoming the center of growth for pharmas of all types. A government official said he expected the future of Gujarat to lie in biotechnology and nanotechnology, which in turn are likely to have an influence on the pharma industry. (Click here for more